Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-sodium peritoneal dialysis solution versus standard isotonic glucose solution in hypertensive peritoneal dialysis patients
2007-005365-35Phase 3Completed
- Sponsor
- Fresenius Medical Care
- Start
- May 2008
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of PDsol 12 in chronic kidney disease (CKD) and hypertension (HTN) (2 arms), sponsored by Fresenius Medical Care. Primary endpoint: Responder rate increase. Started May 2008; status: completed.
02
Drugs
PDsol 12
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)
Beyond the preview
Go deeper on 2007-005365-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005365-35.